Nuo Therapeutics, Inc.

For the period ended Dec 16, 2025. Filed Oct 30, 2025.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Dec 16, 2025 · Filed Oct 30, 2025

AURXStored price and day change unavailable

See the whole filing, with its images and exhibits

Contents

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a party other than the Registrant ☐

Check the appropriate box:

☐	Preliminary Proxy Statement

☐	Confidential, For Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))

☒	Definitive Proxy Statement

☐	Definitive Additional Materials

☐	Soliciting Material Pursuant to Section 240.14a-12

NUO THERAPEUTICS, INC.

(Name of Registrant as Specified in Its Charter)

Payment of Filing Fee (Check all boxes that apply):

☒	No Fee Required

☐	Fee paid previously with preliminary materials

☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

8285 El Rio, Suite 190

Houston, TX 77054

(346) 396-4770

October 30, 2025

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

TO BE HELD ON DECEMBER 16, 2025

Stockholders of Nuo Therapeutics, Inc.:

NOTICE IS HEREBY GIVEN that an Annual Meeting of Stockholders (the “Annual Meeting”) of Nuo Therapeutics, Inc., a Delaware corporation (“Nuo”), will be held on December 16, 2025 at 9 a.m. Central Standard Time at Nuo’s principal executive office at 8285 El Rio, Suite 190, Houston, Texas to conduct the following business:

1.	To elect four directors to serve on Nuo’s Board of Directors, each to serve until Nuo’s next annual meeting of stockholders or until each successor is duly elected and qualified;

2.	To ratify the appointment of MaloneBailey LLP as Nuo’s independent registered public accounting firm for the fiscal year ending December 31, 2025;

3.	To approve, on an advisory basis, the compensation of Nuo’s named executive officers; and

4.	To transact any other business that is properly brought before the Annual Meeting or any adjournment or postponement thereof.

Only stockholders of record at the close of business on October 27, 2025 are entitled to notice of and to vote at the Annual Meeting adjournment or postponement thereof.

by Order of Nuo’s Board of Directors,

/s/ David E. Jorden

David E. Jorden

NOTICE REGARDING INTERNET AVAILABILITY OF PROXY MATERIALS

FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD DECEMBER 16, 2025

This notice, the proxy statement, the proxy card, and Nuo’s annual report on Form 10-K

are available online at https://materials.proxyvote.com/67059V

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.